Eli Lilly Gets More Time To Respond To HHS Letter

By Matthew Perlman · May 28, 2021, 6:06 PM EDT

An Indiana federal court extended the deadline for Eli Lilly to respond to the U.S. Department of Health and Human Services' letter warning it would be fined unless it begins offering...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

ELI LILLY AND COMPANY et al v. HEALTH RESOURCES AND SERVICES ADMINISTRATION, et al

Case Number

1:21-cv-00081

Court

Indiana Southern

Nature of Suit

899(Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision)

Date Filed

January 12, 2021

Recent Articles By Matthew

May 09, 2025
Pathology Lab Urges 8th Circ. Not To Revive Antitrust Claims
April 30, 2025
Monthly Merger Review Snapshot
April 14, 2025
Takeda Gets Actos Case Paused For Class Cert. Review
April 07, 2025
Monthly Merger Review Snapshot
April 02, 2025
Serial Acquisitions Are Still On The FTC's Radar
April 01, 2025
Takeda Antitrust Trial Over Actos Generics Set For July
March 28, 2025
PE Firm Hits Back Against Medical Device Coating Challenge
March 27, 2025
DOJ's Antitrust Unit Targeting Anticompetitive Regulations
March 20, 2025
8th Circ. Won't Pause FTC's Insulin Pricing Case
March 17, 2025
Court Won't Toss Biotech Co.'s Antitrust Counterclaim